News & Updates

Changes in body fat percentage (BFP) are significantly associated with diabetes remission after bariatric surgery, suggests a study, noting that baseline fat-free mass index (FFMI) is vital for BFP changes.

The weight loss and heart failure (HF) benefits of semaglutide extend to patients with obesity-related HF with preserved ejection fraction (HFpEF) and type 2 diabetes (T2D) in the STEP-HFpEF DM trial, fuelling speculation that semaglutide may have cardiovascular effects beyond weight loss.

Use of a smartphone application (app) and an intermittently scanned continuous glucose monitoring (isCGM) results in better glycaemic control, lower carbohydrate intake, and weight loss in people at increased risk of type 2 diabetes (T2D), reports a study.